Company programs are all based in the same platform technology: medical applications with advanced inorganic nanosystems. Our portfolio in development has two leading R&D initiatives:

1. Drug Delivery: EDS is an advanced delivery system for cancer therapeutic agents
   (small molecules and biologicals).
2. Medical Devices: EMD is a medical solution that is designed and will be approved
   for the management and relief of pain associated with oral mucositis.

Apart from our customized programs, the R&D department owns a crucial know-how manipulating inorganic nanosystems for biological applications. Because of that, Endor is a world-class leading company in this emerging field.